Evidence map›Paper›PMID 33057634›Full record

Trial reportBlood advances2020

Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis.

Synne G Fronas, Camilla T Jørgensen, Anders E A Dahm, Hilde S Wik, Jostein Gleditsch, Nezar Raouf, René Holst, F A Klok, Waleed Ghanima

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase III
In one paragraph

Trial report in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02486445 (Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02486445 phase3completednot on this map

Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis

TypeinterventionalSponsorOstfold Hospital TrustRan2015 to 2018Enrolled625ConditionsDeep Venous ThrombosisArmsRivaroxaban
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. External validation of the DAYS score for suspected deep vein thrombosis.Research and practice in thrombosis and haemostasis · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Synne G FronasClinic of Internal Medicine, Department of Emergency Medicine, Østfold Hospital Trust, Grålum, Norway.
Camilla T JørgensenClinic of Internal Medicine, Department of Emergency Medicine, Østfold Hospital Trust, Grålum, Norway.
Anders E A DahmInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Hilde S WikDepartment of Hematology, Oslo University Hospital, Oslo, Norway.
Jostein GleditschDepartment of Radiology, Østfold Hospital Trust, Grålum, Norway.
Nezar RaoufClinic of Internal Medicine, Department of Emergency Medicine, Østfold Hospital Trust, Grålum, Norway.
René HolstClinic of Internal Medicine, Department of Emergency Medicine, Østfold Hospital Trust, Grålum, Norway.
F A KlokDepartment of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands; and.
Waleed GhanimaClinic of Internal Medicine, Department of Emergency Medicine, Østfold Hospital Trust, Grålum, Norway.
Østfold Hospital Trust · NOUniversity of Oslo · NOOslo University Hospital · NOLeiden University Medical Center · NL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Guidelines for the diagnostic workup of deep vein thrombosis (DVT) recommend assessing the clinical pretest probability before proceeding to D-dimer testing and/or compression ultrasonography (CUS) if the patient has high pretest probability or positive D-dimer. Referring only patients with positive D-dimer for whole-leg CUS irrespective of pretest probability may simplify the workup of DVT. In this prospective management outcome study, we assessed the safety of such a strategy. We included consecutive outpatients referred to the Emergency Department at Østfold Hospital, Norway, with suspected DVT between February 2015 and November 2018. STA-Liatest D-Di Plus D-dimer was analyzed for all patients, and only patients with levels ≥0.5 µg/mL were referred for CUS. All patients with negative D-dimer or negative CUS were followed for 3 months to assess the venous thromboembolic rate. One thousand three hundred ninety-seven patients were included. Median age was 64 years (interquartile range, 52-73 years), and 770 patients (55%) were female. D-dimer was negative in 415 patients (29.7%) and positive in 982 patients (70.3%). DVT was diagnosed in 277 patients (19.8%). Six patients in whom DVT was ruled out at baseline were diagnosed with DVT within 3 months of follow-up for a thromboembolic rate of 0.5% (95% confidence interval, 0.2-1.2). A simple diagnostic approach with initial stand-alone D-dimer followed by a single whole-leg CUS in patients with positive D-dimer safely ruled out DVT. We consider this strategy to be a valuable alternative to the conventional workup of DVT in outpatients. This trial was registered at www.clinicaltrials.gov as #NCT02486445.

Indexed as

LegVenous ThrombosisFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedProspective StudiesUltrasonographyFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID33057634
PMCPMC7594381
OpenAlexW3093392739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.